L

Abstract This chapter presents information on neonatal drugs that begin with L, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Labetalol, Lacosamide, Lamivudine, Lamotrigine, Lansoprazole, L-Arginine (Arginine), L-Carnitine (Levocarnitine [INN], carnitine), L-Citrulline, Levetiracetam, Levothyroxine sodium, Lidocaine (Lignocaine—former BAN), Linezolid, Lipid emulsions for parenteral nutrition, Loperamide, Lopinavir with ritonavir, Lorazepam, and Low-molecular-weight heparins and other parenteral anticoagulants.